Home Tags OncoMed Pharmaceuticals

Tag: OncoMed Pharmaceuticals

Financial Analysts Stock Recommendations: OncoMed Pharmaceuticals, Inc. (OMED), FARO Technologies, Inc....

Optimism reigned on a brightened-volume day for OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) which added $0.14 between open and close. The number of shares traders wanted...

A Value Trap Or A Bargain? – OncoMed Pharmaceuticals, Inc. (OMED),...

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) is simply too cheap to pass with a price-to-sales ratio of 6.68. The competitors from Biotechnology hold an average P/S...

Managing Headwinds Better Than Most Peers? – OncoMed Pharmaceuticals, Inc. (OMED),...

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED)'s price-to-sales ratio of 6.68 is creating a long-term opportunity in the value in its stock. The broad Major Pharmaceuticals industry...

Sure Recipe For Successful Investment: Kosmos Energy Ltd. (KOS), OncoMed Pharmaceuticals,...

Shares of Kosmos Energy Ltd. (NYSE:KOS) opened at $6.57, and ended 4.15% higher at $6.78. Nearly 8838589 shares were traded by the close, higher...

Should Value Investors Pick OncoMed Pharmaceuticals, Inc. (OMED), Carrizo Oil &...

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) has a price-to-sales ratio of 0.6, well below its Major Pharmaceuticals competitors. For the industry, the average P/S ratio sits...

OncoMed Pharmaceuticals, Inc. (OMED): A Buffett-Style Stock For The Long Run

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) has made a 56.08% comeback from a 12-month low price of $0.55. It was seen -4.55% lower, changing the price...

Outlook Negative Or Positive? – Heat Biologics, Inc. (HTBX), OncoMed Pharmaceuticals,...

Heat Biologics, Inc. (NASDAQ:HTBX) recorded a trading volume of 1899264 shares, above its 5-day volume average of 1014600 shares. The stock kicked off the...

Investors Brace For Impact: OncoMed Pharmaceuticals, Inc. (OMED), Twilio Inc. (TWLO)

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) recently had a low trading volume day. The volume for the company on 20-Feb-19 was recorded to be 662292 contracts....

You’re Not Crazy to Bet on OncoMed Pharmaceuticals, Inc. (OMED)

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) marched up 55.47% compared to a 52-week low price of $0.55. The shares were last seen trading -4.74% lower, taking...

Analyst Recommendations And Earnings Forecast: OncoMed Pharmaceuticals, Inc. (OMED), Deutsche Bank...

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) last session’s volume of 4218461 shares was higher than its average volume of 970560 shares. The stock, after opening at...